| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0099 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.031 |
0.9 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |